155 related articles for article (PubMed ID: 31255523)
21. Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels.
Karcioglu ZA; El-Yazigi A; Jabak MH; Choudhury AH; Ahmed WS
Ophthalmology; 1998 Apr; 105(4):658-61. PubMed ID: 9544640
[TBL] [Abstract][Full Text] [Related]
22. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
[TBL] [Abstract][Full Text] [Related]
23. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381
[TBL] [Abstract][Full Text] [Related]
24. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.
Lea AP; Lamb HM
Pharmacoeconomics; 1997 Nov; 12(5):596-611. PubMed ID: 10174326
[TBL] [Abstract][Full Text] [Related]
25. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
Steinkamp G; Schmitt-Grohe S; Döring G; Staab D; Pfründer D; Beck G; Schubert R; Zielen S
Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study on azithromycin in 10% fine granules and 100mg capsules in the field of pediatrics].
Motohiro T; Nagai K; Yamada S; Tsumura N; Yamada T; Oda K; Sakata Y; Kato H; Gakuen Y; Imai S; Sasaki H; Morita J; Ikezawa S; Matsuo Y; Yamashita Y; Aramaki M; Araki H; Yasuoka C; Hayashi M; Ono E; Hashimoto N; Kubota K; Kawakami A; Toyoda A; Wada M
Jpn J Antibiot; 1997 Mar; 50(3):272-97. PubMed ID: 9634360
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetic and clinical evaluations of azithromycin in the pediatric field].
Okada T; Machida Y; Fujieda M; Shimazaki Y; Kurashige T
Jpn J Antibiot; 1996 Nov; 49(11):1024-9. PubMed ID: 8988414
[TBL] [Abstract][Full Text] [Related]
28. Dexamethasone improves therapeutic outcomes in a preclinical bacterial epididymitis mouse model.
Klein B; Pant S; Bhushan S; Kautz J; Rudat C; Kispert A; Pilatz A; Wijayarathna R; Middendorff R; Loveland KL; Hedger MP; Meinhardt A
Hum Reprod; 2019 Jul; 34(7):1195-1205. PubMed ID: 31211847
[TBL] [Abstract][Full Text] [Related]
29. [Bacteriological, pharmacokinetic and clinical evaluation of azithromycin in the pediatric field].
Akita H; Sato Y; Kusumoto Y; Iwata S; Takeuchi Y; Aoyama T; Yokota T; Sunakawa K
Jpn J Antibiot; 1996 Oct; 49(10):899-916. PubMed ID: 8986553
[TBL] [Abstract][Full Text] [Related]
30. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.
Manavi K; Hettiarachchi N; Hodson J
Int J STD AIDS; 2016 Dec; 27(14):1303-1308. PubMed ID: 26511655
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of azithromycin for male nongonococcal urethritis.
Takahashi S; Matsukawa M; Kurimura Y; Takeyama K; Kunishima Y; Iwasawa A; Koroku M; Tanda H; Suzuki N; Takagi Y; Hirose T; Nishimura M; Tsukamoto T
J Infect Chemother; 2008 Dec; 14(6):409-12. PubMed ID: 19089553
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacokinetic and clinical evaluation of azithromycin in the pediatric field].
Kitamura K; Kamiya H; Nakano T; Sakurai M
Jpn J Antibiot; 1997 Feb; 50(2):206-14. PubMed ID: 9100081
[TBL] [Abstract][Full Text] [Related]
33. Epididymitis: ascending infection restricted by segmental boundaries.
Stammler A; Hau T; Bhushan S; Meinhardt A; Jonigk D; Lippmann T; Pilatz A; Schneider-Hüther I; Middendorff R
Hum Reprod; 2015 Jul; 30(7):1557-65. PubMed ID: 25994666
[TBL] [Abstract][Full Text] [Related]
34. Epididymitis: aspects concerning etiology and treatment.
Melekos MD; Asbach HW
J Urol; 1987 Jul; 138(1):83-6. PubMed ID: 3474421
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacokinetics and tissue distribution of azithromycin in humans].
Shiba K
Jpn J Antibiot; 2000 Jun; 53 Suppl B():43-59. PubMed ID: 12572088
[TBL] [Abstract][Full Text] [Related]
36. Acute epididymitis and Chlamydia trachomatis.
Nilsson S; Nilsson B; Johannisson G; Lycke E
Ann Chir Gynaecol; 1984; 73(1):42-4. PubMed ID: 6732156
[TBL] [Abstract][Full Text] [Related]
37. Ocular levels of azithromycin.
Tabbara KF; al-Kharashi SA; al-Mansouri SM; al-Omar OM; Cooper H; el-Asrar AM; Foulds G
Arch Ophthalmol; 1998 Dec; 116(12):1625-8. PubMed ID: 9869792
[TBL] [Abstract][Full Text] [Related]
38. PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections.
Mishra MK; Kotta K; Hali M; Wykes S; Gerard HC; Hudson AP; Whittum-Hudson JA; Kannan RM
Nanomedicine; 2011 Dec; 7(6):935-44. PubMed ID: 21658474
[TBL] [Abstract][Full Text] [Related]
39. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
Jeong BH; Jeon K; Park HY; Moon SM; Kim SY; Lee SY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):6076-83. PubMed ID: 27480854
[TBL] [Abstract][Full Text] [Related]
40. [A new therapeutic approach in the treatment of genital chlamydial infections. Azithromycin (Sumamed)].
Borisov I
Akush Ginekol (Sofiia); 1998; 37(3):58-62. PubMed ID: 10204275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
